ETANERCEPT
- UNII: OP401G7OJC
- Preferred Substance Name: ETANERCEPT
- 185243-69-0
- 1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
- CHS-0214
- DAVICTREL
- DWP-422
- ENBREL
- ENBREL [PURPLE BOOK CDER]
- ENIA-11
- ERELZI
- ETANERCEPT (ENBREL)
- ETANERCEPT [EMA EPAR]
- ETANERCEPT [EP MONOGRAPH]
- ETANERCEPT [HSDB]
- ETANERCEPT [INN]
- ETANERCEPT [JAN]
- ETANERCEPT [MART.]
- ETANERCEPT [MI]
- ETANERCEPT [PURPLE BOOK CDER]
- ETANERCEPT [USAN]
- ETANERCEPT [VANDF]
- ETANERCEPT [WHO-DD]
- ETANERCEPT BIOSIMILAR ((YLB-113)
- ETANERCEPT BIOSIMILAR (GP-2015)
- ETANERCEPT BIOSIMILAR (SAMSUNG BIOEPIS)
- ETANERCEPT BIOSIMILAR (SANDOZ)
- ETANERCEPT BIOSIMILAR (SB-4)
- ETANERCEPT SZZS [WHO-DD]
- ETANERCEPT YKRO [WHO-DD]
- ETANERCEPT, LICENSE HOLDER UNSPECIFIED
- ETANERCEPT-SZZS
- ETANERCEPT-SZZS [PURPLE BOOK CDER]
- ETANERCEPT-YKRO
- ETICOVO
- GP2015
- GP-2015
- GP2015C
- HD203
- HD-203
- LBEC0101
- LBEC-0101
- RHU TNFR:FC
- RHU-TNFR:FC
- SB4
- SB-4
- TNFR-IMMUNOADHESIN
- TUNEX
- YLB113
- YLB-113
About, Contact Us, Copyright, Privacy, Accessibility
U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002
U.S. Food and Drug Administration, Health & Human Services
Powered by
